Familial Hypophosphatemic Rickets: all 61 studies

Page 1 of 1. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.

• Morphology in Oral Rare Syndromes & Artificial Intelligence for Clinical DiagnosisNot yet recruitingNCT07666269Not applicable
• Effective Dosing of Burosumab in XLHRecruitingNCT07183579
• Phosphorus-31 Spectroscopy in Phosphate DiabetesRecruitingNCT06921720Not applicable
• A First-in-human Study of KK8123 in Adults With X-linked HypophosphatemiaRecruitingNCT06525636Phase 1/2
• Effect of Burosumab on the Inflammatory Profile of Patients With X-linked Hypophosphatemic Rickets FLAM-XLHNot yet recruitingNCT06248632
• National Registry of Rare Kidney DiseasesRecruitingNCT06065852
• Prevention of Spontaneous Dental Abscesses in Children With X-linked Hypophosphatemia : a RCTNot yet recruitingNCT04872907Phase 3
• Expanded Access to BurosumabAvailableNCT03775187
• Registry for Patients With X-Linked HypophosphatemiaRecruitingNCT03193476
• Examining the Effect of Burosumab on Muscle FunctionCompletedNCT04146935Phase 4Results posted
• Calcitriol Monotherapy for X-Linked HypophosphatemiaCompletedNCT03748966Early Phase 1Results posted
• Efficacy and Safety of Burosumab Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With XLHCompletedNCT02915705Phase 3Results posted
• Study of the Safety, Pharmacodynamics (PD) and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)CompletedNCT02750618Phase 2Results posted
• Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)CompletedNCT02537431Phase 3Results posted
• Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH)CompletedNCT02526160Phase 3Results posted
• Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)CompletedNCT02312687Phase 2Results posted
• Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)CompletedNCT02163577Phase 2Results posted
• Calcitonin for Treating X-linked HypophosphatemiaCompletedNCT01652573Not applicableResults posted
• An Extension Study of KRN23 in Adults With X-Linked HypophosphatemiaCompletedNCT01571596Phase 1/2Results posted
• A Repeated Study of KRN23 in Adults With X-Linked HypophosphatemiaCompletedNCT01340482Phase 1/2Results posted
• Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic RicketsCompletedNCT00417612Phase 3Results posted
• Treatment Patterns, Biochemical Profiles and Clinical Outcomes in Adults With X-Linked HypophosphatemiaWithdrawnNCT07607600
• The ENABLE Study: Safety and Efficacy Study of INZ-701 in Patients With ENPP1 DeficiencyWithdrawnNCT06739980Phase 2
• Foot Disorders in X-linked HypophosphatemiaCompletedNCT06067932
• Baby Detect : Genomic Newborn ScreeningCompletedNCT05687474
• A Study to Describe the Lived Experience of XLH for Adolescents at End of Skeletal GrowthCompletedNCT05181839
• Burden of Disease and Functional Impairment in XLHActive, not recruitingNCT04946409
• Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLHCompletedNCT04842032Phase 4
• Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLHCompletedNCT04842019Phase 4
• A UK Multicentre, Health-Related Quality of Life Study for Children and Adolescents With XLHCompletedNCT04819490
• Anti-FGF23 (Burosumab) in Adult Patients With XLHCompletedNCT04695860Phase 3
• Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 DeficiencyCompletedNCT04686175Phase 1/2
• Burosumab in Children and Adolescents With X-linked HypophosphatemiaStatus unknownNCT04419363Phase 4
• Understanding the Spectrum of ENPP1 Deficiency and Acute ABCC6 DeficiencyCompletedNCT04372446
• A Study of KRN23 in Adult and Pediatric Patients With X-linked Hypophosphatemic Rickets/OsteomalaciaCompletedNCT04308096Phase 3
• Characterising Pain, QoL, Body Composition, Arterial Stiffness, Muscles and Bones in Adult Persons With XLH and Healthy ControlsCompletedNCT04273490
• Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of AgeCompletedNCT04188964Phase 1/2
• Burosumab and 1-25 (OH) Vitamin D on Human OsteoclastsCompletedNCT04184661
• Retrospective and Prospective Disease Progression and Quality of Life in XLHCompletedNCT04049877
• Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLHCompletedNCT03920072Phase 3
• Dental Implants in Patients With X-linked HypophosphatemiaStatus unknownNCT03879915
• Using Different Doses of Active Vitamin D Combined With Neutral Phosphate in Children With X-linked HypophosphatemiaStatus unknownNCT03820518Phase 4
• Natural History of GACI With or Without ARHR2 or PXEStatus unknownNCT03758534
• Study of Longitudinal Observation for Patient With X-linked Hypophosphatemic Rickets/Osteomalacia in Collaboration With Asian PartnersActive, not recruitingNCT03745521
• Early Check: Expanded Screening in NewbornsActive, not recruitingNCT03655223
• X-linked Hypophosphatemia Disease Monitoring ProgramActive, not recruitingNCT03651505
• X-linked Hypophosphatemia and FGF21CompletedNCT03596554
• Open Label Trial Assessing Safety and Efficacy of Burosumab (KRN23), in a Patient With ENS and Hypophosphatemic RicketsCompletedNCT03581591Phase 3
• FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)CompletedNCT03489993
• Milk Products in the Treatment of Hypophosphatemic RicketsCompletedNCT03348644Not applicable
• A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/OsteomalaciaCompletedNCT03233126Phase 3
• Growth Hormone Treatment in Children With Hypophosphatemic RicketsCompletedNCT02720770Phase 1/2
• Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.CompletedNCT02233322Not applicable
• A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/OsteomalaciaCompletedNCT02181764Phase 1
• Assessment Of Vitamin D Role In The Pathogenesis Of Asthma In Vitamin D Resistent PatientsCompletedNCT01578824Not applicable
• Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic RicketsCompletedNCT01237288Phase 3
• Hypophosphatemic Rickets in NorwayStatus unknownNCT01057186
• Calcimimetics in Hypophosphatemic RicketsWithdrawnNCT00844740Not applicable
• A Study of KRN23 in X-linked HypophosphatemiaCompletedNCT00830674Phase 1
• Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic RicketsStatus unknownNCT00473187Phase 1
• Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic RicketsCompletedNCT00195936Phase 1

← Familial Hypophosphatemic Rickets overview